Development and characterization of a multiplex bead-based immunoassay to quantify pneumococcal capsular polysaccharide-specific antibodies

David L. Klein, Joseph E. Martinez, Michael H. Hickey, F. Hassouna, K. Zaman, Mark Steinhoff

Research output: Contribution to journalArticle

Abstract

Enzyme-linked immunosorbent assay (ELISA), the traditional antibody quantification technique, has several limitations, especially when used to evaluate multivalent and/or infant vaccines. We have developed a multiplex bead-based antibody quantification assay (MBIA) to measure antibody response to multiple pneumococcal (Pn) serotypes (St) in a single assay. MBIA was compared with theWHOELISA using aWHOpanel of 12 international calibration sera for 7 Pn Sts. An agreement of 75 to 92% was obtained for all 7 Sts. MBIA exhibited good robustness, with the assay variability at ≤16%. A major contributor to MBIA variability was the cell wall polysaccharide (CWPs) content in Pn St-specific capsular Ps. This necessitated careful CWPs (20 μg/ml) preadsorption of sera. MBIA is specific, robust, and reproducible and offers high throughput. The use of MBIA will greatly reduce the cost and time required to evaluate the immune response to multiple Pn Sts and could help promote the licensure of future Pn and other multivalent vaccines.

Original languageEnglish (US)
Pages (from-to)1276-1282
Number of pages7
JournalClinical and Vaccine Immunology
Volume19
Issue number8
DOIs
StatePublished - Aug 2012

Fingerprint

Immunoassay
Cell Wall
Polysaccharides
Assays
Vaccines
Antibodies
Licensure
Serum
Calibration
Antibody Formation
Enzyme-Linked Immunosorbent Assay
Costs and Cost Analysis
Immunosorbents
Cells
Throughput
Serogroup
Enzymes
Costs

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Development and characterization of a multiplex bead-based immunoassay to quantify pneumococcal capsular polysaccharide-specific antibodies. / Klein, David L.; Martinez, Joseph E.; Hickey, Michael H.; Hassouna, F.; Zaman, K.; Steinhoff, Mark.

In: Clinical and Vaccine Immunology, Vol. 19, No. 8, 08.2012, p. 1276-1282.

Research output: Contribution to journalArticle

Klein, David L. ; Martinez, Joseph E. ; Hickey, Michael H. ; Hassouna, F. ; Zaman, K. ; Steinhoff, Mark. / Development and characterization of a multiplex bead-based immunoassay to quantify pneumococcal capsular polysaccharide-specific antibodies. In: Clinical and Vaccine Immunology. 2012 ; Vol. 19, No. 8. pp. 1276-1282.
@article{c88a6d6d4b004d75aefba2049bd36a90,
title = "Development and characterization of a multiplex bead-based immunoassay to quantify pneumococcal capsular polysaccharide-specific antibodies",
abstract = "Enzyme-linked immunosorbent assay (ELISA), the traditional antibody quantification technique, has several limitations, especially when used to evaluate multivalent and/or infant vaccines. We have developed a multiplex bead-based antibody quantification assay (MBIA) to measure antibody response to multiple pneumococcal (Pn) serotypes (St) in a single assay. MBIA was compared with theWHOELISA using aWHOpanel of 12 international calibration sera for 7 Pn Sts. An agreement of 75 to 92{\%} was obtained for all 7 Sts. MBIA exhibited good robustness, with the assay variability at ≤16{\%}. A major contributor to MBIA variability was the cell wall polysaccharide (CWPs) content in Pn St-specific capsular Ps. This necessitated careful CWPs (20 μg/ml) preadsorption of sera. MBIA is specific, robust, and reproducible and offers high throughput. The use of MBIA will greatly reduce the cost and time required to evaluate the immune response to multiple Pn Sts and could help promote the licensure of future Pn and other multivalent vaccines.",
author = "Klein, {David L.} and Martinez, {Joseph E.} and Hickey, {Michael H.} and F. Hassouna and K. Zaman and Mark Steinhoff",
year = "2012",
month = "8",
doi = "10.1128/CVI.05535-11",
language = "English (US)",
volume = "19",
pages = "1276--1282",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Development and characterization of a multiplex bead-based immunoassay to quantify pneumococcal capsular polysaccharide-specific antibodies

AU - Klein, David L.

AU - Martinez, Joseph E.

AU - Hickey, Michael H.

AU - Hassouna, F.

AU - Zaman, K.

AU - Steinhoff, Mark

PY - 2012/8

Y1 - 2012/8

N2 - Enzyme-linked immunosorbent assay (ELISA), the traditional antibody quantification technique, has several limitations, especially when used to evaluate multivalent and/or infant vaccines. We have developed a multiplex bead-based antibody quantification assay (MBIA) to measure antibody response to multiple pneumococcal (Pn) serotypes (St) in a single assay. MBIA was compared with theWHOELISA using aWHOpanel of 12 international calibration sera for 7 Pn Sts. An agreement of 75 to 92% was obtained for all 7 Sts. MBIA exhibited good robustness, with the assay variability at ≤16%. A major contributor to MBIA variability was the cell wall polysaccharide (CWPs) content in Pn St-specific capsular Ps. This necessitated careful CWPs (20 μg/ml) preadsorption of sera. MBIA is specific, robust, and reproducible and offers high throughput. The use of MBIA will greatly reduce the cost and time required to evaluate the immune response to multiple Pn Sts and could help promote the licensure of future Pn and other multivalent vaccines.

AB - Enzyme-linked immunosorbent assay (ELISA), the traditional antibody quantification technique, has several limitations, especially when used to evaluate multivalent and/or infant vaccines. We have developed a multiplex bead-based antibody quantification assay (MBIA) to measure antibody response to multiple pneumococcal (Pn) serotypes (St) in a single assay. MBIA was compared with theWHOELISA using aWHOpanel of 12 international calibration sera for 7 Pn Sts. An agreement of 75 to 92% was obtained for all 7 Sts. MBIA exhibited good robustness, with the assay variability at ≤16%. A major contributor to MBIA variability was the cell wall polysaccharide (CWPs) content in Pn St-specific capsular Ps. This necessitated careful CWPs (20 μg/ml) preadsorption of sera. MBIA is specific, robust, and reproducible and offers high throughput. The use of MBIA will greatly reduce the cost and time required to evaluate the immune response to multiple Pn Sts and could help promote the licensure of future Pn and other multivalent vaccines.

UR - http://www.scopus.com/inward/record.url?scp=84864572816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864572816&partnerID=8YFLogxK

U2 - 10.1128/CVI.05535-11

DO - 10.1128/CVI.05535-11

M3 - Article

C2 - 22739691

AN - SCOPUS:84864572816

VL - 19

SP - 1276

EP - 1282

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 8

ER -